GLUCONEOGENESIS AND INTRAHEPATIC TRIOSE PHOSPHATE FLUX IN RESPONSE TO FASTING OR SUBSTRATE LOADS - APPLICATION OF THE MASS ISOTOPOMER DISTRIBUTION ANALYSIS TECHNIQUE WITH TESTING OF ASSUMPTIONS AND POTENTIAL PROBLEMS

被引:126
作者
NEESE, RA
SCHWARZ, JM
FAIX, D
TURNER, S
LETSCHER, A
VU, D
HELLERSTEIN, MK
机构
[1] UNIV CALIF BERKELEY, DEPT NUTR SCI, BERKELEY, CA 94720 USA
[2] UNIV CALIF SAN FRANCISCO, SAN FRANCISCO GEN HOSP, DEPT MED, DIV ENDOCRINOL & METAB, SAN FRANCISCO, CA 94101 USA
关键词
D O I
10.1074/jbc.270.24.14452
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We measured gluconeogenesis (GNG) in rats by mass isotopomer distribution analysis, which allows enrichment of the true biosynthetic precursor pool (hepatic cytosolic triose phosphates) to be determined. Fractional GNG from infused [3-C-13]lactate, [1-C-13]lactate, and [2-C-13]glycerol was 88 +/- 2, 89 +/- 3, and 87 +/- 2%, respectively, after 48 h of fasting, [2-C-13]Glycerol was the most efficient label and allowed measurement of rate of ap appearance of intrahepatic triose phosphate (Ra triose-P), by dilution. IV fructose (10-15 mg/kg/min) increased absolute GNG by 81-147%, Ra triose-P increased proportionately, but endogenous Ra triose-P was almost completely suppressed, suggesting feedback control, Interestingly, 15-17% of fructose was directly converted to glucose without entering hepatic triose-P, IV glucose reduced GNG and Ra triose-P, 24-h fasting reduced hepatic glucose production by half, but absolute GNG was unchanged due to increased fractional GNG (51-87%). Reduced hepatic glucose production was entirely due to decreased glycogen input, from 7.3 +/- 1.8 to 1.1 +/- 0.2 mg/kg/min, Ra triose-P fell during fasting, but efficiency of triose-P disposal into GNG increased, maintaining GNG constant, Secreted glucuronyl conjugates and plasma glucose results correlated closely, In summary, GNG and intrahepatic triose-P flux can be measured by mass isotopomer distribution analysis with [2-C-13]glycerol.
引用
收藏
页码:14452 / 14463
页数:12
相关论文
共 59 条
  • [11] DETERMINATION OF FRUCTOSE METABOLIC PATHWAYS IN NORMAL AND FRUCTOSE-INTOLERANT CHILDREN - A C-13 NMR-STUDY USING [U-C-13]FRUCTOSE
    GOPHER, A
    VAISMAN, N
    MANDEL, H
    LAPIDOT, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (14) : 5449 - 5453
  • [12] QUANTITATION OF POSITIONAL ISOMERS OF DEUTERIUM-LABELED GLUCOSE BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY
    GUO, ZK
    LEE, WNP
    KATZ, J
    BERGNER, AE
    [J]. ANALYTICAL BIOCHEMISTRY, 1992, 204 (02) : 273 - 282
  • [13] EFFECTS OF CIGARETTE-SMOKING AND ITS CESSATION ON LIPID-METABOLISM AND ENERGY-EXPENDITURE IN HEAVY SMOKERS
    HELLERSTEIN, MK
    BENOWITZ, NL
    NEESE, RA
    SCHWARTZ, JM
    HOH, R
    JACOB, P
    HSIEH, J
    FAIX, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) : 265 - 272
  • [14] GLYCOCONJUGATES AS NONINVASIVE PROBES OF INTRAHEPATIC METABOLISM - PATHWAYS OF GLUCOSE ENTRY INTO COMPARTMENTALIZED HEPATIC UDP-GLUCOSE POOLS DURING GLYCOGEN ACCUMULATION
    HELLERSTEIN, MK
    GREENBLATT, DJ
    MUNRO, HN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (18) : 7044 - 7048
  • [15] RATE OF GLUCOSE ENTRY INTO HEPATIC URIDINE DIPHOSPHOGLUCOSE BY THE DIRECT PATHWAY IN FASTED AND FED STATES IN NORMAL HUMANS
    HELLERSTEIN, MK
    KAEMPFER, S
    REID, JS
    WU, K
    SHACKLETON, CHL
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (02): : 172 - 182
  • [16] INTERLEUKIN-1-INDUCED ANOREXIA IN THE RAT - INFLUENCE OF PROSTAGLANDINS
    HELLERSTEIN, MK
    MEYDANI, SN
    MEYDANI, M
    WU, K
    DINARELLO, CA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (01) : 228 - 235
  • [17] HELLERSTEIN MK, 1992, AM J PHYSIOL, V263, pE988
  • [18] MEASUREMENT OF DENOVO HEPATIC LIPOGENESIS IN HUMANS USING STABLE ISOTOPES
    HELLERSTEIN, MK
    CHRISTIANSEN, M
    KAEMPFER, S
    KLETKE, C
    WU, K
    REID, JS
    MULLIGAN, K
    HELLERSTEIN, NS
    SHACKLETON, CHL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (05) : 1841 - 1852
  • [19] HELLERSTEIN MK, 1991, J BIOL CHEM, V266, P10920
  • [20] USE OF MASS ISOTOPOMER DISTRIBUTIONS IN SECRETED LIPIDS TO SAMPLE LIPOGENIC ACETYL-COA POOL INVIVO IN HUMANS
    HELLERSTEIN, MK
    KLETKE, C
    KAEMPFER, S
    WU, K
    SHACKLETON, CHL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (04): : E479 - E486